Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial
Status:
Recruiting
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
The trial of IV arginine therapy in children with Vaso-occlusive painful episodes (VOE) in
sickle cell disease (SCD) is designed to further knowledge on efficacy and safety of the
therapy.